Literature DB >> 17165096

Anxiolytic effect of serotonin depletion in the novelty-induced hypophagia test.

Anita J Bechtholt1, Tiffany E Hill, Irwin Lucki.   

Abstract

RATIONALE: Relatively little is known about the neural mechanisms underlying anxiety in the novelty-induced hypophagia test, the only known anxiety test that is responsive to chronic but not acute or subchronic antidepressant treatment.
OBJECTIVES: The goal of the present experiment was to characterize the role of serotonin in the ability of novelty to suppress feeding.
MATERIALS AND METHODS: Pair-housed male Sprague-Dawley rats were trained to eat graham cracker crumbs individually in their home cage (15 min/day). After stable daily intakes were obtained, the animals were depleted of serotonin using 4-chloro-DL -phenylalanine (150 mg kg(-1) day(-1) x 2 days). Forty-eight hours later, central serotonin was restored by the administration of the peripheral L -aromatic amino acid decarboxylase inhibitor, benserazide (10 mg/kg), followed 15 min later with the immediate precursor of serotonin, 5-hydroxy-L -tryptophan (30 mg/kg). Thirty minutes later, the animals were given access to graham cracker crumbs in a novel environment.
RESULTS: The animals demonstrated increased latencies to approach the food and reduced food intake in the novel environment. This effect was attenuated by serotonin depletion. Repletion of central serotonin restored the inhibitory response to novelty. The analysis of serotonin content in different brain regions confirmed that serotonin was depleted by greater than 90%, whereas the repletion treatment resulted in serotonin levels similar to nondepleted animals.
CONCLUSIONS: Acute depletion of serotonin acts to reduce anxiety behavior as measured by an inhibitory anxiety response during exposure to novel stimuli. These findings are in agreement with the proposed general role for serotonin in behavioral inhibition and that reductions of serotonin facilitate the adoption of more active coping responses to stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17165096     DOI: 10.1007/s00213-006-0615-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  41 in total

1.  Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection.

Authors:  G A Higgins; B J Jones; N R Oakley
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test.

Authors:  Stephanie C Dulawa; Rene Hen
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

3.  Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice.

Authors:  Zul Merali; Carla Levac; Hymie Anisman
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

4.  Evidence for the involvement of the 5-HT1A receptor in the anxiolytic action of indorenate and ipsapirone.

Authors:  A Fernández-Guasti; C López-Rubalcava
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder.

Authors:  E Hollander; C DeCaria; R Gully; A Nitescu; R F Suckow; J M Gorman; D F Klein; M R Liebowitz
Journal:  Psychiatry Res       Date:  1991-01       Impact factor: 3.222

6.  Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice.

Authors:  A J Mayorga; A Dalvi; M E Page; S Zimov-Levinson; R Hen; I Lucki
Journal:  J Pharmacol Exp Ther       Date:  2001-09       Impact factor: 4.030

Review 7.  Behavioral correlates of serotonin depletion.

Authors:  J A Harvey; A J Schlosberg; L M Yunger
Journal:  Fed Proc       Date:  1975-08

8.  The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study.

Authors:  Y Minabe; K Emori; C R Ashby
Journal:  Synapse       Date:  1996-01       Impact factor: 2.562

Review 9.  Depression: a case of neuronal life and death?

Authors:  Ronald S Duman
Journal:  Biol Psychiatry       Date:  2004-08-01       Impact factor: 13.382

10.  SSRI treatment decreases prolactin and hyperthermic responses to mCPP.

Authors:  D J Quested; P A Sargent; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  1997-10       Impact factor: 4.530

View more
  18 in total

1.  Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences.

Authors:  Nicolas Narboux-Nême; Corinne Sagné; Stephane Doly; Silvina L Diaz; Cédric B P Martin; Gaelle Angenard; Marie-Pascale Martres; Bruno Giros; Michel Hamon; Laurence Lanfumey; Patricia Gaspar; Raymond Mongeau
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

2.  Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.

Authors:  Jill R Turner; Laura M Castellano; Julie A Blendy
Journal:  J Pharmacol Exp Ther       Date:  2010-04-30       Impact factor: 4.030

3.  Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats.

Authors:  Gregory V Carr; Lee E Schechter; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2010-03-09       Impact factor: 4.530

4.  Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.

Authors:  Jill R Turner; Derek S Wilkinson; Rachel Lf Poole; Thomas J Gould; Gregory C Carlson; Julie A Blendy
Journal:  Neuropsychopharmacology       Date:  2013-04-29       Impact factor: 7.853

5.  Antidepressant-like effects of buprenorphine in rats are strain dependent.

Authors:  Caroline A Browne; Duncan S van Nest; Irwin Lucki
Journal:  Behav Brain Res       Date:  2014-10-18       Impact factor: 3.332

6.  Constitutive Increases in Amygdalar Corticotropin-Releasing Factor and Fatty Acid Amide Hydrolase Drive an Anxious Phenotype.

Authors:  Luis A Natividad; Matthew W Buczynski; Melissa A Herman; Dean Kirson; Christopher S Oleata; Cristina Irimia; Ilham Polis; Roberto Ciccocioppo; Marisa Roberto; Loren H Parsons
Journal:  Biol Psychiatry       Date:  2017-01-13       Impact factor: 13.382

7.  Effect of antidepressants on body weight, ethology and tumor growth of human pancreatic carcinoma xenografts in nude mice.

Authors:  Lin Jia; Yuan-Yuan Shang; Yu-Yuan Li
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

8.  Bi-directional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes.

Authors:  J-D Guo; S E Hammack; R Hazra; L Levita; D G Rainnie
Journal:  Neuroscience       Date:  2009-09-22       Impact factor: 3.590

9.  Transient serotonin depletion at adolescence, but not at early infancy, reduced subsequent anxiety-like behavior and alcohol intake in female mice.

Authors:  Fabio Bellia; Andrea Suarez; Claudio D'Addario; Ricardo Marcos Pautassi; María Carolina Fabio
Journal:  Psychopharmacology (Berl)       Date:  2020-10-04       Impact factor: 4.530

10.  The effects of congenital brain serotonin deficiency on responses to chronic fluoxetine.

Authors:  B D Sachs; J P R Jacobsen; T L Thomas; W B Siesser; W L Roberts; M G Caron
Journal:  Transl Psychiatry       Date:  2013-08-13       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.